Skip to contentApplication 203107
- Type
- ANDA
- Sponsor
- MAYNE PHARMA INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | CAPSULE;ORAL | 5MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 68308-145 | Oxycodone Hydrochloride | Oxycodone Hydrochloride | Mayne Pharma Inc. | ANDA | Current |
| 68308-145 | Oxycodone Hydrochloride | Oxycodone Hydrochloride | Mayne Pharma Inc. | ANDA | Current |
| 68308-145 | Oxycodone Hydrochloride | Oxycodone Hydrochloride | Mayne Pharma Inc. | ANDA | Current |
| 68308-145 | Oxycodone Hydrochloride | Oxycodone Hydrochloride | Mayne Pharma Inc. | ANDA | Current |
| 68308-145 | Oxycodone Hydrochloride | Oxycodone Hydrochloride | Mayne Pharma Inc. | ANDA | Current |
| 68308-145 | Oxycodone Hydrochloride | Oxycodone Hydrochloride | Mayne Pharma Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 76111 | ORIG | 2023-11-02 |